BMS-954561

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBMS-954561
Drug Alias NameBMS-954561
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonistsMuscle-type nicotinic acetylcholine receptor antagonists
TargetsGamma-aminobutyric acid A receptorMuscle-type nicotinic acetylcholine receptor
Therapy Area/IndicationsNeuralgia, PostherpeticDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol Myers Squibb Srlcompany
Active IndicationsN/A
Inactive IndicationsNeuralgia, PostherpeticDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A